Senate Amendment 2122 in the Nature of a Substitute to S. 3187, the Food and Drug Administration Safety and Innovation Act with Further Amendments Adopted by the Senate Through May 24, 2012

Cost Estimate

CBO Estimate of the Statutory Pay-As-You-Go Effects for Senate Amendment 2122 in the Nature of a Substitute to S. 3187,the Food and Drug Administration Safety and Innovation Act, with Further Amendments Adopted by the Senate through May 24, 2012